Jivial Industries Ltd submitted a regulatory disclosure to BSE Limited pursuant to Regulation 32(I) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.
The disclosure confirms there is no deviation or variation in the utilization of funds raised through the company's Initial Public Offer (IPO) for the half year ended September 30, 2026.
Key Financial Details
- IPO Date: 29th June, 2026
- Amount Raised: ₹2,664.82 lakhs through issuance of 13,59,600 equity shares of face value ₹10 each at an issue price of ₹196 per share (entirely fresh issue)
- Total Funds Utilized: ₹1,619.58 lakhs as of September 30, 2026
- Monitoring Agency: Not Applicable
Fund Utilization Breakdown
| Object | Original Allocation (₹ in Lakhs) | Funds Utilized (₹ in Lakhs) | Deviation/Variation |
| Purchase new machineries | 1,440.00 | 515.00 | NIL |
| Capital expenditure for renovation of manufacturing facility | 400.00 | 302.74 | NIL |
| Corporate General Purpose | 399.39 | 376.41 | NIL |
| Issue related expenses | 425.43 | 425.43 | NIL |
| Total | 2,664.82 | 1,619.58 | |
Governance and Compliance
- The statement was reviewed by the Audit Committee in its meeting held on November 05, 2026
- The Audit Committee noted that there is no deviation or variation in the utilization of the IPO proceeds from the objects stated in the Prospectus
- No comments from auditors were provided
- No shareholder approval was required as there was no deviation
- The disclosure was signed by Anand Jitendrabhai Chovatiya, Managing Director (DIN: 09212897)